Medimaps Product Theater: Introducing TBS Osteo v4

Only available as part of a package
LOCATION: Georgian room

PROGRAM: For over a decade, Trabecular Bone Score (TBS) has been used in clinical setting,  complementing FRAX® and BMD to improve the detection of bone fragilities in patients at risk of fractures. TBS Osteo is the only regulatory software approved worldwide for indirectly evaluating bone microarchitecture status in clinical settings from 2D images, and is supported by four category 1 CPT® codes for reimbursement in the U.S.

Building on 14 years of product evolution to meet clinicians’ needs, the new TBS Osteo v4 software is designed to enhance evaluation capabilities. It represents a significant clinical advancement by offering a broader patient eligibility, and technical interoperability within the radiology practice.

Join Medimaps Group Product Theater to learn more about the new TBS Osteo v4 features and its clinical performance in patients suffering from pathologies impacting bone microarchitecture.

SPEAKERS:

image

Univ.-Prof. Dr. Didier Hans
Head of Research and Development, Interdisciplinary Center of Bone Diseases at Lausanne University Hospital and CEO & Co-Founder of Medimaps Group

 

image

Univ.-Prof. Dr. Karen Hind
Honorary Professor at Lancaster University Medical School, UK and Senior Director of Clinical Affairs, Research and Innovation at Medimaps Group

---

Product Theaters are sponsored presentations and there is no credit available. A boxed lunch will be provided to the first 80 attendees.

Product Theaters are sponsored presentations and there is no credit available.

Components visible upon registration.
;